Home › Research › Topics › intracerebroventricular-streptozotocin
intracerebroventricular-streptozotocin
3 studies tagged intracerebroventricular-streptozotocin, dated 2012-10-11 to 2023-04-20. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease 2023-04-20
- Intracerebroventricular streptozotocin impairs adult neurogenesis and cognitive functions via regulating neuroinflammation and insulin signaling in adult rats 2017-11-22
- Attenuating effect of lisinopril and telmisartan in intracerebroventricular streptozotocin induced experimental dementia of Alzheimer's disease type: possible involvement of PPAR-γ agonistic property 2012-10-11
Studies
3 studies carry this tag.
Date range
2012 to 2023
Top journals
- Journal of the renin-angiotensin-aldosterone system : JRAAS 1
- Neurochemical research 1
- Neurochemistry international 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Alzheimer's disease (AD) is an age-related, multifactorial progressive neurodegenerative disorder manifested by cognitive impairment and neuronal death in the brain areas like hippocampus, yet the precise neuropathology of AD is still unclear.
-
Neurogenesis is a complex process involved in memory formation and is known to be altered in Alzheimer's disease (AD).
-
This study investigates the beneficial role of lisinopril, an angiotensin converting enzyme inhibitor (ACEI) and telmisartan, an angiotensin receptor blocker (ARB), in intracerebroventricular (i.c.v.) streptozotocin (STZ) induced dementia of Alzheimer's disease (AD) type in mice.